Trial Profile
A Phase 1 Clinical Study to Assess the Effect of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Darunavir; Lopinavir; Ritonavir
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 11 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jun 2014 New trial record